In contrast, although SPTLC2 was also highly expressed in AD, it did not reach a statistically significant level (p > 0.05) (Figure 11A), which may be influenced by sample specificity and requires further validation in subsequent studies. Here, SPTLC2 is linked to Alzheimer disease.